Nyxoah is trading 10.69% up at $1.60 on September 28, 2026, with no clear company-specific catalyst identified. - The latest company news was a September 21 CFO transition and reaffirmed 2026 guidance, not a fresh catalyst. - Nyxoah is scheduled to present at the Cantor Healthcare Conference later today. - Broader markets are risk-off, with oil prices rising after the U.S. rejected Iran’s proposal and Treasury yields near multiyear highs; that backdrop does not explain Nyxoah’s gain.